Skip to main content
Beijing Wandong Medical Technology Co., Ltd. logo

Beijing Wandong Medical Technology Co., Ltd. — Investor Relations & Filings

Ticker · 600055 ISIN · CNE000000PZ1 LEI · 3003005SK71U1661FX19 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600055

About Beijing Wandong Medical Technology Co., Ltd.

https://www.wandong.com.cn/

Beijing Wandong Medical Technology Co., Ltd. specializes in the research, development, manufacturing, and distribution of advanced medical imaging equipment. The company provides a comprehensive portfolio of diagnostic solutions, including digital X-ray systems, magnetic resonance imaging (MRI) scanners, computed tomography (CT) systems, and digital subtraction angiography (DSA) units. Wandong also offers medical imaging cloud services and integrated diagnostic platforms. The company serves a global market, providing healthcare facilities with high-performance imaging technology designed to improve diagnostic accuracy and clinical efficiency. Its commitment to innovation is reflected in its extensive R&D capabilities and a diverse range of products tailored for various clinical applications, from routine screenings to complex interventional procedures.

Recent filings

Filing Released Lang Actions
万东医疗关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement by Beijing Wandong Medical Technology Co., Ltd. regarding the receipt of a medical device registration certificate from the National Medical Products Administration. It details the certificate number, product specifications, approval and effective dates, and includes an impact and risk disclosure. There are no financial results, management change disclosures, voting results, or capital structure updates. This falls under general regulatory announcements and compliance information that do not fit other specific categories, so it should be classified as a Regulatory Filing (RNS).
2026-05-22 Chinese
万东医疗关于2025年股票期权激励计划首次及预留授予第一个行权期行权条件未成就及注销部分股票期权的公告
Regulatory Filings Classification · 85% confidence The document is a formal corporate announcement by Beijing Wandong Medical regarding the cancellation of unvested stock options under its 2025 stock option incentive plan due to unfulfilled performance conditions and departures. It is not an earnings release, regulatory stress test, governance policy overview, board/management change, or capital raising. It does not contain full financial statements or detailed supplemental data. It formally notifies shareholders via the exchange but does not itself constitute a financial report. Thus it falls under general Regulatory Filings (RNS) as a miscellaneous corporate announcement.
2026-05-22 Chinese
万东医疗2025年年度股东会会议资料
AGM Information Classification · 95% confidence The document is the complete set of materials and agenda for the company’s 2025 Annual General Meeting (AGM), including the meeting agenda, directors’ work report, financial statements, and shareholder proposals. It is not merely an announcement but the full AGM materials provided to shareholders. This matches the definition of AGM Information (AGM-R).
2026-04-14 Chinese
万东医疗关于召开2025年年度暨2026年第一季度业绩说明会的公告
Investor Presentation Classification · 85% confidence The document is a formal announcement by Beijing Wandong Medical Technology Co., Ltd. regarding the date, time, and logistics of an upcoming “2025 Annual and 2026 Q1 Performance Briefing” for investors. It does not contain the actual financial results or slides but rather provides details on how investors can participate and pose questions. This aligns with an Investor Presentation announcement rather than a report itself or a regulatory filing of results. Therefore, it should be classified under the Investor Presentation category (IP).
2026-04-14 Chinese
立信会计师事务所关于万东医疗2025年度募集资金存放、管理与使用情况专项报告的鉴证报告
Audit Report / Information Classification · 87% confidence The document is a CPA’s verification (鉴证) report on the company’s special report regarding the deposit, management, and use of funds raised in 2025. It is an independent assurance engagement by registered accountants, containing audit scope, responsibilities, and audit conclusions, rather than being the company’s own annual/interim report or a simple announcement. This matches the definition of a standalone Audit Report/Information filing (Code: AR). FY 2025
2026-03-25 Chinese
万东医疗审计委员会对会计师事务所履行监督职责的情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Audit Committee regarding the supervision of the accounting firm (立信会计师事务所) in relation to the company's 2025 annual audit. It discusses the audit firm's qualifications, independence, audit procedures, communication with management, audit fees, and the committee's evaluation of the audit firm's performance. The document references the 2025 annual financial report and internal control audit but does not contain the financial statements or the audit report itself. Instead, it is a supervisory report on the audit process and the audit firm's conduct. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and information about audit processes and results of internal or regulatory reviews, excluding the full Annual Report. The document length (2561 characters) and content confirm it is not the full Annual Report (10-K) or a brief announcement. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-03-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.